Patient groups in appraisals of NHS drugs receiving undeclared funds from manufacturers

London School of Hygiene and Tropical Medicine review calls for stronger policy on disclosure and greater transparency from patient organisations and manufacturers to ensure that healthcare decisions made by NICE are not unduly influenced by industry. DB Recovery+ asks: would that and NICE members interests account for pharma-leaning advice on alcohol & drugs?